Main Article Content


The purpose of this study was to evaluate the potential antidiabetic drug Triphala guggul (TG), an indigenous polyherbal Ayurvedic formulation in an alloxan-induced diabetes rat model. Diabetes mellitus was induced in rats. The rats were divided into nine groups, including the groups of normal control which received the vehicle, the standard group (Glibenclamide) and rats with induced diabetes were treated with the tablet of Triphala guggul and Triphala guggul churna in doses of 100, 200, 400 mg/kg body weight, respectively. They were administered orally for 28 days on a single dose. Blood was collected from the vein in the tail on days 7, 14, 21 and 28. Biochemical estimates were made using blood serum. Acute toxicity studies did not reveal toxicity in rats. For 28 days, Administration of Triphala guggul tablet and Triphala guggul churna formulations improved oral glucose tolerance in diabetes-induced rats and after 28 days, resulted in a significant reduction in serum glucose level compared to normal control rats. These formulations do not affect the kidney, adipose tissue, and liver. The Triphala guggul formulation has a promising antidiabetic property and is effective in the treatment of diabetes.


Alloxan monohydrate Antidiabetic activity Diabetes mellitus Triphala Guggul

Article Details

How to Cite
Krishna Murthy, Snehal D. Jagadale, Solunke R. S., Shete R. V., & Priyanka Nangare. (2020). Antidiabetic potential of Triphala Guggul - an ayurvedic formulation in alloxan-induced diabetes animal model. International Journal of Research in Pharmaceutical Sciences, 11(1), 315-322.